These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5400176)

  • 21. [Hepatic encephalopathy--therapy].
    Wettstein M; Häussinger D
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2658-60. PubMed ID: 14673743
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatic encephalopathy.
    Córdoba J; Mínguez B
    Semin Liver Dis; 2008 Feb; 28(1):70-80. PubMed ID: 18293278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of thiamphenicol. Behavior in a acute and chronic hepatic insufficiency].
    Menz HP; Bezler HJ; Hartmann I; von Oldershausen HF
    Arzneimittelforschung; 1974 Jan; 24(1):99-102. PubMed ID: 4406121
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathogenesis of hepatic coma].
    Capocaccia L; Rossi Fanelli F; Cascino A; Cangiano C; Calcaterra V; de Conciliis D; Gentile S; Merli M; Riggio O; Stortoni M; Giunchi G
    Recenti Prog Med; 1981 Apr; 70(4):358-99. PubMed ID: 6114522
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of aminoacid and protein metabolism disturbances in liver disease (author's transl)].
    Gerok W
    Leber Magen Darm; 1981 Apr; 11(2):63-72. PubMed ID: 6785546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acids in liver disease.
    Hagenfeldt L; Eriksson LS; Wahren J
    Proc Nutr Soc; 1983 Sep; 42(3):497-506. PubMed ID: 6361777
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity.
    O'Keefe SJ; Abraham R; El-Zayadi A; Marshall W; Davis M; Williams R
    Gastroenterology; 1981 Dec; 81(6):1017-24. PubMed ID: 7286580
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of methylprednisolone on protein metabolism of the brain and liver in subjects with healthy liver and liver cirrhosis (catheterization of the hepatic vein and internal jugular vein)].
    Klein C; Müting D; Bette L; Blaise H
    Verh Dtsch Ges Inn Med; 1969; 75():322-4. PubMed ID: 5400140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amino acid metabolism in hepatic encephalopathy].
    Szostak D
    Wiad Lek; 1988 Mar; 41(5):327-35. PubMed ID: 3218243
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatic encephalopathy].
    Rózga J; Szczerbań J
    Pol Tyg Lek; 1980 Jan; 35(4):117-20. PubMed ID: 7053045
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatobiliary nutrition: history and future.
    Dudrick SJ; Kavic SM
    J Hepatobiliary Pancreat Surg; 2002; 9(4):459-68. PubMed ID: 12483268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.
    Sugimoto R; Iwasa M; Maeda M; Urawa N; Tanaka H; Fujita N; Kobayashi Y; Takeda K; Kaito M; Takei Y
    Am J Gastroenterol; 2008 Jun; 103(6):1413-20. PubMed ID: 18510613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
    Ferenci P; Wewalka F
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amnoniacal detoxication and cerearal metabolism].
    Nordmann R
    Cah Coll Med Hop Paris; 1967 Mar; 8(3):185-90. PubMed ID: 5614605
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
    Novelli A; Reali EF; Amato M; Dami A; Fallani S; Periti P
    J Chemother; 1989 Jul; 1(4 Suppl):546-8. PubMed ID: 16312526
    [No Abstract]   [Full Text] [Related]  

  • 37. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
    Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
    Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ammoniuria and its relation to hydroionic factors and to the precoma situation in liver cirrhosis: the kidney as an excretory organ of ammonia].
    Barrio Gómez E; Sánchez Creus P; Gómez Pérez M; Gilsanz Rico G; Pérez Oteiza C
    Rev Clin Esp; 1975 Dec; 139(6):497-504. PubMed ID: 2953
    [No Abstract]   [Full Text] [Related]  

  • 39. [D-thyroxine metabolism in hepatic insufficiency].
    Morgner KD; Krüskemper HL; Seifert E
    Verh Dtsch Ges Inn Med; 1969; 75():334-6. PubMed ID: 5400143
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood ammonia level in liver cirrhosis: a conditio sine qua non to confirm hepatic encephalopathy?
    Gundling F; Seidl H; Schmidt T; Schepp W
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):246-7. PubMed ID: 18301310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.